咖啡酸乙醇封装在自组装的米纳米颗粒中:储存稳定性,体外释放以及它们的相互作用机制
Xinyue Wang1, Siyi Feng1, Hongdong Song1,2
1School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Foods (Basel, Switzerland)
|March 13, 2024
概括
米的纳米颗粒有效封装咖啡酸乙烯 (CAPE),显著提高其水溶性和稳定性. 这种新的纳米载体系统显示出改善CAPE的前景.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 咖啡酸乙烯 (CAPE) 是一种在中发现的生物活性化合物.
- 低水溶性和储存稳定性限制了CAPE的实际应用.
- 需要新的交付系统来克服Cape的局限性.
研究的目的:
- 开发一个纳米载体系统用于CAPE使用自组装的米.
- 描述米纳米颗粒 (RPN) 的物理化学特性.
- 评估封装CAPE的增强溶解性,稳定性和释放特征.
主要方法:
- 通过可控制的米酶解来制造RPN.
- 描述RPN的有效直径,封装效率和负载能力.
- 评估CAPE溶解性,储存稳定性和RPNs的体外释放动力学.
主要成果:
- RPN 的有效直径为 ~210 nm,封装效率高 (77.77%) 和负载能力高 (3.89%).
- 在RPNs封装后,CAPE的水溶性增加了45倍.
- RPNs显著改善了CAPE的存储稳定性,并延迟了其体外释放.
结论:
- 自组装的RPN作为CAPE的有效纳米载体.
- RPNs显著提高了CAPE的水溶性和储存稳定性.
- 这种纳米粒子系统为改善CAPE交付和生物可用性提供了一个有希望的策略.
关键词:
CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE CAPE was born in the late 1960s when he was born in the late 1960s when he was born in the late 1960s光灭的光灭类是大米中的类.自动组装的自动组装机在水中溶解度水溶性.
相关概念视频
01:28Factors Influencing Drug Absorption: Pharmaceutical Parameters
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:16Drug Product Stability
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
01:20Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
01:22Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...